Oramed Pharmaceuticals
ORMP
#9233
Rank
S$0.21 B
Marketcap
S$5.08
Share price
-1.00%
Change (1 day)
70.93%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): S$81 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of S$79.81 Million, an increase over its 2024 earnings that were of -S$19.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$81 M1.49%
2025 S$79.81 M-513.21%
2024 -S$19.32 Million-311.47%
2023 S$9.13 M-119.45%
2022 -S$46.96 Million39.17%
2021 -S$33.74 Million73.93%
2020 -S$19.4 Million18.53%
2019 -S$16.37 Million-16.62%
2018 -S$19.63 Million38.32%
2017 -S$14.19 Million12.51%
2016 -S$12.62 Million25.01%
2015 -S$10.09 Million18.18%
2014 -S$8.54 Million39.72%
2013 -S$6.12 Million46.4%
2012 -S$4.18 Million128.32%
2011 -S$1.83 Million-51.47%
2010 -S$3.77 Million35.21%
2009 -S$2.79 Million
2007 -S$4.39 Million607.04%
2006 -S$0.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
S$29.76 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$9.17 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-S$0.65 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-S$78.35 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
S$44.71 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel